Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

2.82
Delayed Data
As of 3:59pm ET
 +0.12 / +4.44%
Today’s Change
2.35
Today|||52-Week Range
9.07
-65.23%
Year-to-Date
No recent news for Cardiome Pharma Corp.

Today’s Trading

Previous close2.70
Today’s open2.70
Day’s range2.70 - 2.82
Volume16,571
Average volume (3 months)101,393
Market cap$86.1M
Dividend yield--
Data as of 3:59pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-19.64%
Earnings growth (this year)+49.13%
Earnings growth (next 5 years)--
Revenue growth (last year)-30.40%
P/E ratio--
Price/Sales6.97
Price/Book2.73

Competitors

 Today’s
change
Today’s
% change
SCYXSCYNEXIS Inc+0.03+0.84%
NBRVNabriva Therapeutics...+0.04+0.95%
GEMPGemphire Therapeutic...+0.18+1.96%
SPHSSophiris Bio Inc-0.01-0.36%
Data as of 3:59pm ET, 12/05/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$20.9M
Annual profit (last year)-$24.5M
Net profit margin-116.99%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William L. Hunter
Chief Operating Officer
Sheila M. Grant
Corporate headquarters
Vancouver, British Columbia

Forecasts


Search for Jobs